Latest Dermatology Headlines: Study Links Psoriasis and OCD, DermTech Files for Chapter 11 Bankruptcy Protection, and More

Psoriasis Linked to Obsessive-Compulsive Disorder (OCD) in US Adults

A recent study conducted by researchers at Yale School of Medicine found a correlation between individuals with psoriasis and an increased likelihood of being diagnosed with obsessive-compulsive disorder (OCD). The study, which used data from the All of Us Research Program, is the first of its kind that focuses on American adults.

The researchers discovered that people with psoriasis had a 1.5-fold increase in the odds of being diagnosed with OCD. Possible reasons for this connection include psoriasis symptoms such as itching leading to a predisposition for OCD and shared inflammatory pathways between the two conditions. Patients with psoriasis may now have an increased understanding of the need to discuss mental health with their doctors.

Keywords: psoriasis, obsessive-compulsive disorder, mental health, inflammation, All of Us Research Program

DermTech Files for Chapter 11 Bankruptcy Protection

Despite efforts to reduce costs and stabilize finances, San Diego-based company DermTech has filed for Chapter 11 bankruptcy protection. DermTech is known for its skin cancer detection sticker, which is noninvasive. The restructuring is expected to involve the sale of assets while allowing for the continued operation of DermTech’s laboratory services.

Although DermTech is filing for bankruptcy protection, the company still hopes to continue serving its patients and advance technology that facilitates skin cancer detection. This may be an opportunity for other companies to invest in DermTech and help lead in the development of noninvasive skin cancer detection technology.

Keywords: DermTech, Chapter 11 bankruptcy protection, skin cancer detection, laboratory services, noninvasive technology

European Court of Justice Rules Against Advertising “Skin-Friendly” Disinfectants

The European Court of Justice recently ruled that disinfectants cannot be advertised as “skin friendly.” The decision was made after a German court case against a drugstore chain that labeled its hand, skin, and surface disinfectant as “skin friendly.” The court found that this labeling violates European Union (EU) regulations on biocidal products, which prohibit promoting them with terms such as low-risk, non-toxic, harmless, natural, environmentally friendly, animal friendly, or any similar indication.

According to the EU court, calling a disinfectant “skin friendly” implies positive connotations that can mislead consumers into believing that the product is beneficial for the skin, thus justifying its prohibition in advertising. As such, customers now will not be misled into believing that disinfectants can provide a positive benefit to their skin in any way, which will help to maintain transparency in the advertisement and product labeling of disinfectants.

Keywords: European Court of Justice, disinfectants, skin-friendly, EU regulations, consumer protection

Conclusion

These latest headlines in dermatology show that the field is continuously evolving, and patients can benefit from staying updated on the latest news. The study linking psoriasis to OCD shows the importance of discussing mental health with dermatologists, while the bankruptcy filing and ruling on disinfectant labeling demonstrate the impact of financial management in companies and transparency in the labeling of products.

Originally Post From https://www.dermatologytimes.com/view/derm-in-the-news-june-16-22

Read more about this topic at
The Weekly Roundup: June 17-21
Dermatology Roundup Archives – JDDonline